NCT04572542 2020-10-01
Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer
The First Affiliated Hospital of Xiamen University
Phase 1/2 Unknown
Clinical Trials
1 trialsPhase 1/2 × Locally Advanced or Metastatic Gastric Adenocarcinoma × 130-nm albumin-bound paclitaxel × Clear all